Журналов:     Статей:        

Валеология: Здоровье, Болезнь, Выздоровление. 2020; : 211-217

СРАВНИТЕЛЬНАЯ ЭФФЕКТИВНОСТЬ ВИДОВ АЛЛЕРГОДИАГНОСТИКИ В РЕГИОНЕ С МНОЖЕСТВЕННЫМИ ПЫЛЬЦЕВЫМИ ВОЗДЕЙСТВИЯМИ

САЛТАБАЕВА У. Ш.

Аннотация

   В данной статье отражены результаты сравнительной эффективности молекулярной аллергодиагностики с определением аллергенной молекулы на основе серологического IgE с традиционными кожными скариффикационными пробами на основе экстрактов для назначения аллерген-специфической иммунотерапии (АСИТ).

Список литературы

1. Canonica G. W., Pawankar R., Holgate S. T. et al. In: WAO WHITE BOOK on allergy // World Allergy Organization. – Milwaukee; Wisconsin, 2013. – 20 р.

2. Perkin M. R., Genuneit J. et al Overview of systematic reviews in allergy epidemiology // Allergy. - 2017. – Vol. 149, №1. - P. 32-37.

3. Brozek J. L., Cuello-Garcia C. A. et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics // World Allergy Organization Journal. – 2016. – Vol. 1, № 3. - P. 466-476.

4. Намазова-Баранова Л. С. Аллергия у детей: от теории – к практике / Л. С. Намазова-Баранова. – Серия «Современная педиатрия». - М., 2011. - 668 c.

5. Моренко М. А. Клинико-фармакологическое обоснование целесообразности включения препаратов глицирризиновой кислоты в систему фармакотерапии бронхиальной астмы у детей: дис. … докт. мед. наук: 14. 00. 25. / М. А. Моренко - Астана, 2010. – 220 с.

6. Ильина Н. И. Современные аспекты решения актуальных проблем аллергологии в России / Н. И. Ильина, К. С. Павлова // Ремедиум. - 2016. - № 1-2. - С. 28-30.

7. Bousquet J., Canonica G. W., Valenta R. et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle // Clinical and Translational Allergy – 2016. - Vol. 6 - P. 1-47.

8. Global strategy for asthma management and prevention. – http://goldcopd.org.

9. Papadopoulos N. G., Hatzler L., Hofmaier S. et al. Allergic airway diseases in childhood - marching from epidemiology to novel concepts of prevention // Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. – 2012. – Vol. 23, № 7. – P. 616-622.

10. Курбачева О. М. Аллерген-специфическая иммунотерапия: история, методы и новые возможности / О. М. Курбачева [и др.] // Медицинский совет. – 2013. – № 3-2. – С. 10-19.

11. Маслова Л. В. Эпидемиологические аспекты аллергического ринита в Республике Беларусь / Л. В. Маслова // Ars medica. – 2012. – № 11. – С. 61–66.

12. Calderon M. A., Penagos M., Sheikh A., Canonica G. W. et al. Sublingual immunotherapy for allergic conjunctivitis: cochrane systematic review and meta-analysis // Clinical And Experimental Allergy. – 2011. – Vol. 7. - P. 1263–1272.

13. Zhumambayeva S., Rozenson R., Tawfik A. et al. Date of birth and hay fever risk in children and adolescents of Kazakhstan // International Journal of Pediatric Otorhinolaryngology. – 2014. – Vol. 78, № 2. – P. 214-217.

14. Климат Астаны / Министерство природных ресурсов и охраны окружающей среды Республики Казахстан. – www.eco.gov.kz (Материал).

15. Becker S., Schlederer T., Kramer M. F., Haack M. et al: Real-Life Study for the Diagnosis of House Dust Mite Allergy - The Value of Recombinant Allergen-Based IgE Serology // Int Arch Allergy Immunol. – 2016 – Vol. 170. - P. 132-137.

16. Canonica G. W., Ansotegui I. J., Pawankar R. et al. A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics // World Allergy Organization Journal. – 2013. - Vol. 6, №1. – Р. 1-17.

17. Fooke-Achterrath M., Rubina A. Y., Feizkhanova G. U., Filippova M. A. et al. Multiplex assay of allergen-specific and total immunoglobulins of E and G classes in the biochip format // Biochem Biophys. – 2012 - Vol. 447. - P. 289-293.

18. Spergel J. M. From atopic dermatitis to asthma: the atopic march // Ann Allergy Asthma Immunol. – 2010. – Vol. 30 - P. 269–280.

19. Valenta R., Linhart B., Niederberger V. et al. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens // Allergy. – 2011 – Vol. 66. - P. 775–783.

20. Saltabayeva U. et al. Allergen-specific immunotherapy in patients with pollinosis // II-oj tarptautinės sveikatos mokslų studentų konf. Ir 18-oji tarptautinės mokslinės-praktinės konferencijos». - Klaipėda, 2016. - Р. 143.

21. Saltabayeva U., Morenko M., Garib V., Rozenson R. Comparative assessment of the effectiveness of the allergenspecific immunotherapy types with pollinosis / The European Academy of Allergy and Clinical Immunology Annual Congress.

22. Saltabayeva U., Morenko M., Garib V., Rozenson R. et al. Superior economic efficacy of allergen molecule-based diagnosis for prescription of immunotherapy in an area with multiple pollen exposure: a real life study // Annual Meeting of the OEGAI. – Innsbruck, 2016. – P. 51.

23. Saltabayeva U., Morenko M., Garib V., Rozenson R. et al. Greater Real-Life Diagnostic Efficacy of Allergen Molecule-Based Diagnosis for Prescription of Immunotherapy in an Area with Multiple Pollen Exposure // International Archives of Allergy and Immunology. - 2017. Vol. 173, № 2 – P. 93–98.

24. Borghesan F., Bernardi D., Plebani M. In vivo and in vitro allergy diagnostics: it is time to reappraise the costs // Clin Chem Lab Med. – 2007. – Vol. 45, № 3. - P. 391-395.

25. Ma S., Nie L., Li H., Wang R., Yin J. Component-Resolved Diagnosis of Peanut Allergy and Its Possible Origins of Sensitization in China // Int Arch Allergy Immunol. – 2016. – Vol. 169. – P. 241-248.

26. Melioli G., Bonifazi F. et al. Passalacqua G. et al. The Immuno CAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms // Clin Biochem. – 2011. – Vol. 44, № 12. - P. 1005–1011.

27. Bergmann K. C. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis // J. All. Clin. Immunol. - 2014 – Vol. 133, № 6. - P. 608-1614.

28. Sampson H. A., Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis // J Allergy Clin Immunol. – 1984. – Vol. 74. - P. 26-33.

29. Demoly P., Passalacqua G. et al Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose // Clinical and Translational Allergy. – 2015. - Vol. 5 - P. 1-44.

30. Салтабаева У. Ш. Сравнительная оценка эффективности видов аллерген-специфической иммунотерапии при поллинозе: дис. … докт. философии: 6D110100 / У. Ш. Салтабаева. - Астана, 2017. – 200 с.

Valeology: Health - Illnes - recovery. 2020; : 211-217

COMPARATIVE EFFICACY OF ALLERGIC DIAGNOSIS IN THE REGION WITH MULTIPLE POLLEN EXPOSURE

SALTABAYEVA U. SH.

Abstract

   This article reflects the results of the comparative effectiveness of molecular allergy diagnostics. In addition to that, an allergenic molecule was determined based on serological IgE with traditional skin extracts, depending on extracts for administering allergen-specific immunotherapy.

References

1. Canonica G. W., Pawankar R., Holgate S. T. et al. In: WAO WHITE BOOK on allergy // World Allergy Organization. – Milwaukee; Wisconsin, 2013. – 20 r.

2. Perkin M. R., Genuneit J. et al Overview of systematic reviews in allergy epidemiology // Allergy. - 2017. – Vol. 149, №1. - P. 32-37.

3. Brozek J. L., Cuello-Garcia C. A. et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics // World Allergy Organization Journal. – 2016. – Vol. 1, № 3. - P. 466-476.

4. Namazova-Baranova L. S. Allergiya u detei: ot teorii – k praktike / L. S. Namazova-Baranova. – Seriya «Sovremennaya pediatriya». - M., 2011. - 668 c.

5. Morenko M. A. Kliniko-farmakologicheskoe obosnovanie tselesoobraznosti vklyucheniya preparatov glitsirrizinovoi kisloty v sistemu farmakoterapii bronkhial'noi astmy u detei: dis. … dokt. med. nauk: 14. 00. 25. / M. A. Morenko - Astana, 2010. – 220 s.

6. Il'ina N. I. Sovremennye aspekty resheniya aktual'nykh problem allergologii v Rossii / N. I. Il'ina, K. S. Pavlova // Remedium. - 2016. - № 1-2. - S. 28-30.

7. Bousquet J., Canonica G. W., Valenta R. et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle // Clinical and Translational Allergy – 2016. - Vol. 6 - P. 1-47.

8. Global strategy for asthma management and prevention. – http://goldcopd.org.

9. Papadopoulos N. G., Hatzler L., Hofmaier S. et al. Allergic airway diseases in childhood - marching from epidemiology to novel concepts of prevention // Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. – 2012. – Vol. 23, № 7. – P. 616-622.

10. Kurbacheva O. M. Allergen-spetsificheskaya immunoterapiya: istoriya, metody i novye vozmozhnosti / O. M. Kurbacheva [i dr.] // Meditsinskii sovet. – 2013. – № 3-2. – S. 10-19.

11. Maslova L. V. Epidemiologicheskie aspekty allergicheskogo rinita v Respublike Belarus' / L. V. Maslova // Ars medica. – 2012. – № 11. – S. 61–66.

12. Calderon M. A., Penagos M., Sheikh A., Canonica G. W. et al. Sublingual immunotherapy for allergic conjunctivitis: cochrane systematic review and meta-analysis // Clinical And Experimental Allergy. – 2011. – Vol. 7. - P. 1263–1272.

13. Zhumambayeva S., Rozenson R., Tawfik A. et al. Date of birth and hay fever risk in children and adolescents of Kazakhstan // International Journal of Pediatric Otorhinolaryngology. – 2014. – Vol. 78, № 2. – P. 214-217.

14. Klimat Astany / Ministerstvo prirodnykh resursov i okhrany okruzhayushchei sredy Respubliki Kazakhstan. – www.eco.gov.kz (Material).

15. Becker S., Schlederer T., Kramer M. F., Haack M. et al: Real-Life Study for the Diagnosis of House Dust Mite Allergy - The Value of Recombinant Allergen-Based IgE Serology // Int Arch Allergy Immunol. – 2016 – Vol. 170. - P. 132-137.

16. Canonica G. W., Ansotegui I. J., Pawankar R. et al. A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics // World Allergy Organization Journal. – 2013. - Vol. 6, №1. – R. 1-17.

17. Fooke-Achterrath M., Rubina A. Y., Feizkhanova G. U., Filippova M. A. et al. Multiplex assay of allergen-specific and total immunoglobulins of E and G classes in the biochip format // Biochem Biophys. – 2012 - Vol. 447. - P. 289-293.

18. Spergel J. M. From atopic dermatitis to asthma: the atopic march // Ann Allergy Asthma Immunol. – 2010. – Vol. 30 - P. 269–280.

19. Valenta R., Linhart B., Niederberger V. et al. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens // Allergy. – 2011 – Vol. 66. - P. 775–783.

20. Saltabayeva U. et al. Allergen-specific immunotherapy in patients with pollinosis // II-oj tarptautinės sveikatos mokslų studentų konf. Ir 18-oji tarptautinės mokslinės-praktinės konferencijos». - Klaipėda, 2016. - R. 143.

21. Saltabayeva U., Morenko M., Garib V., Rozenson R. Comparative assessment of the effectiveness of the allergenspecific immunotherapy types with pollinosis / The European Academy of Allergy and Clinical Immunology Annual Congress.

22. Saltabayeva U., Morenko M., Garib V., Rozenson R. et al. Superior economic efficacy of allergen molecule-based diagnosis for prescription of immunotherapy in an area with multiple pollen exposure: a real life study // Annual Meeting of the OEGAI. – Innsbruck, 2016. – P. 51.

23. Saltabayeva U., Morenko M., Garib V., Rozenson R. et al. Greater Real-Life Diagnostic Efficacy of Allergen Molecule-Based Diagnosis for Prescription of Immunotherapy in an Area with Multiple Pollen Exposure // International Archives of Allergy and Immunology. - 2017. Vol. 173, № 2 – P. 93–98.

24. Borghesan F., Bernardi D., Plebani M. In vivo and in vitro allergy diagnostics: it is time to reappraise the costs // Clin Chem Lab Med. – 2007. – Vol. 45, № 3. - P. 391-395.

25. Ma S., Nie L., Li H., Wang R., Yin J. Component-Resolved Diagnosis of Peanut Allergy and Its Possible Origins of Sensitization in China // Int Arch Allergy Immunol. – 2016. – Vol. 169. – P. 241-248.

26. Melioli G., Bonifazi F. et al. Passalacqua G. et al. The Immuno CAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms // Clin Biochem. – 2011. – Vol. 44, № 12. - P. 1005–1011.

27. Bergmann K. C. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis // J. All. Clin. Immunol. - 2014 – Vol. 133, № 6. - P. 608-1614.

28. Sampson H. A., Albergo R. Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis // J Allergy Clin Immunol. – 1984. – Vol. 74. - P. 26-33.

29. Demoly P., Passalacqua G. et al Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose // Clinical and Translational Allergy. – 2015. - Vol. 5 - P. 1-44.

30. Saltabaeva U. Sh. Sravnitel'naya otsenka effektivnosti vidov allergen-spetsificheskoi immunoterapii pri pollinoze: dis. … dokt. filosofii: 6D110100 / U. Sh. Saltabaeva. - Astana, 2017. – 200 s.